- **Revenue and Margin Growth**: 2025 revenue up 1.4% to $346.8M, EBITDA +23% to $68.7M. Q4 EBITDA margin 22% (+160bps YoY). 2026 targets: modest revenue growth, 200bps EBITDA margin expansion.
- **Pipeline and AI Momentum**: $19.8M Q4 bookings (TCV), 53% pipeline growth. AI initiatives reduce documentation time by 50%-75%, with encoder pipeline +74%.
- **Financial Strength**: Free cash flow $20M (2025), net debt $139.8M (2x leverage). New $250M credit facility improves liquidity.
- **Customer Retention and Strategy**: Global workforce transition model improves retention. Strategic review underway to maximize shareholder value.

**【CEO Summary Section】**
- **Strategic Review and Financial Health**: CEO Chris Fowler announced a strategic review process to maximize shareholder value, with a focus on modest 2026 revenue growth and 200 basis points of EBITDA margin expansion. The company achieved $87.2M Q4 revenue (flat YoY, excluding Centriq sunset) and $19.2M adjusted EBITDA (22% margin, +160bps YoY). Full-year revenue grew 1.4% to $346.8M, with EBITDA up 23% to $68.7M.
- **Pipeline and Bookings Momentum**: Q4 bookings of $19.8M (TCV) reflect 53% pipeline growth since Q3, driven by recurring deals (70% of pipeline) and higher-margin encoder solutions (+74% pipeline). Full-year bookings reached $82.9M (TCV), up 1% YoY.
- **Customer Retention and AI Strategy**: Improved retention through a structured transition model and new Global Capacity Center in Chennai. AI initiatives across financial health, patient care, and internal operations aim to enhance efficiency and customer experience, with early pilots showing 50%-75% reduction in documentation time.

**【CFO Financial Commentary】**
- **Cash Flow and Debt Optimization**: Free cash flow of $20M (2025) reflects disciplined capital allocation. Net debt reduced by $19.5M YoY to $139.8M, with a 2x net leverage ratio. A new $250M credit facility extends maturity and lowers cost of capital.
- **Margin Expansion Drivers**: 350bps EBITDA margin expansion in 2025 from cost optimization (IT, cloud, patient care support) and offshore workforce transition. Gross margin improved 120bps QoQ to 53%, with Financial Health gross margin up 65bps.
- **Revenue Mix Shift**: Encoder and SaaS growth (higher margins) offset service-based revenue declines. Patient Care revenue (+4% ex-Centriq) reflects SaaS adoption.

**【Q&A Highlights】**
- **Bookings Conversion and Pipeline Quality**: CFO Vinay Bassi emphasized bookings-to-revenue conversion through attrition modeling. CEO highlighted pipeline diversification (14% to 30% of pipeline from >100-bed hospitals) and improved deal quality (70% recurring revenue).
- **AI and Regulatory Impact**: AI-driven efficiency in claims denial prediction and patient care documentation (50%-75% time reduction) positions TruBridge to capitalize on rural health funding ($50B EHR modernization initiative). Competitive differentiation through Ambient Technology pilots and customer-facing AI chatbots.
- **Strategic Review and Capital Allocation**: No timeline for strategic review resolution. Focus on debt reduction, share buybacks, and high-ROI investments in AI and encoder solutions.

TruBridge, Inc. (TBRG) Q4 2025 Earnings Call Transcript

- **Revenue Resilience**: Q3 2025 revenue grew 2% YoY to $86.1 million, with 94% recurring revenue.
- **Bookings Quality Focus**: Q3 bookings of $15.5 million underperformed but reflected strategic shift to high-margin Encoder deals (+100% YoY bookings growth).
- **Margin Expansion Roadmap**: 2026 EBITDA margin expansion of 200+ basis points expected from cost savings ($35M debt reduction since Q1 2024) and offshore transitions.
- **Sales Leadership Impact**: New CBO Mike Daughton is reorganizing sales to target 100-400-bed hospitals, where Financial Health bookings have grown to 30% of total (vs. <20% in 2024).
- **Operational Efficiency**: Capitalized software spend down 30% YoY, and free cash flow improved $20M year-to-date 2025.

**【CEO Summary Section】**
- **Revenue Growth**: Total revenue for Q3 2025 was $86.1 million, up 2% year-over-year (2.8% excluding the sunset of the Centriq product). Recurring revenue represented 94% of total revenue.
- **Bookings Performance**: Q3 bookings were $15.5 million (TCV), under expectations but focused on higher-margin deals. October bookings exceeded historical trends, signaling potential pipeline conversion acceleration.
- **Strategic Initiatives**: 
  - **Offshore Transition**: Resumed with 2 customer transitions in Q4, targeting 200+ basis points of EBITDA margin expansion by 2026 through cost savings and improved client retention.
  - **Sales Leadership**: Mike Daughton, new Chief Business Officer, is restructuring sales, marketing, and client success to enhance pipeline quality and conversion.
  - **Encoder Growth**: Year-to-date Encoder bookings doubled, contributing 70-80% margins.

**【CFO Financial Commentary】**
- **Profitability**: Adjusted EBITDA margin for Q3 was 18.9% ($16.3 million), up 155 basis points year-over-year. Full-year 2025 guidance for adjusted EBITDA is $65-68 million (19% margin), with 2026 targeting 200+ basis points of further expansion.
- **Cash Flow & Debt**: Free cash flow year-to-date 2025 was $15 million (vs. -$5 million in 2023). Net debt reduced by $35 million since Q1 2024 to $144 million, with leverage ratio improving to 2.2x.
- **Cost Optimization**: Capitalized software spend decreased 30% YoY to $12.5 million, and operating expenses were flat at $40 million (46% of revenue).

**【Q&A Key Highlights】**
- **Pipeline & Bookings Quality**: Q3 bookings underperformed by ~20%, but October bookings indicate delayed decisions are resolving. Focus on high-margin Encoder and SaaS conversions is driving 30%+ growth in 100-400-bed Financial Health bookings.
- **Margin Expansion Drivers**: 
  - **Cost Control**: 2026 EBITDA margin expansion of 200+ basis points expected from continued cost optimization and offshore transitions.
  - **Revenue Mix**: Higher-margin Encoder and SaaS bookings (e.g., 60% gross margin in Patient Care) are improving overall profitability.
  - **Client Retention**: Net retention rate improving in Q3, with renewed focus on client success and transition process transparency.
- **Regulatory Impact**: Medicaid funding uncertainty is delaying some decisions, but the rural hospital funding bill (OBBB) is expected to create tailwinds for 2026 RCM investments.

TruBridge, Inc. (TBRG) Q3 2025 Earnings Call Transcript

- **Revenue Growth & Margin Expansion**: Q2 bookings up 10% YoY, EBITDA margin 16% (vs. 15.7% YoY). FY25 EBITDA guidance raised to 18.5% midpoint.
- **India Strategy**: Physical office in 2026 to drive 2026+ growth through standardized workflows and productivity improvements.
- **AI Innovation**: Microsoft Copilot integration for EHR, AI-driven client support tools enhance efficiency and client experience.
- **Client Retention Focus**: 21/26 CBO renewals YTD; India office and resource management to improve retention in 2026.
- **Debt Reduction**: 2.4x net leverage (vs. 3.9x YoY), $32.5M debt paid since Jan 2024.


**【CEO Summary Section】**
- **CMS Interoperability Pledge**: Signed at the White House, emphasizing commitment to rural healthcare through modern data infrastructure and AI-driven solutions.
- **Q2 Financials**: Bookings of $25.6M (10% YoY growth), revenue $85.7M (flat YoY), adjusted EBITDA $13.7M (16% margin). Revised FY25 guidance: Revenue $345-350M, EBITDA $62-67M (up 200bps YoY).
- **Client Retention Challenges**: CBO renewals at 21/26 year-to-date, with plans to improve through resource management, India office (2026), and leadership hires.
- **Strategic Initiatives**: 
  - **India Expansion**: Physical office to standardize workflows, enhance productivity, and support 2026+ growth.
  - **AI Integration**: Microsoft Copilot for EHR, AI-driven client support tools for efficiency.
  - **Encoder Growth**: 13% QoQ bookings, higher gross margins driving profitability.

**【CFO Financial Commentary】**
- **Cash Flow**: $14.5M YoY increase in operating cash flow, free cash flow $5.5M (up 200% YoY).
- **Debt Reduction**: 2.4x net leverage (down from 3.9x YoY), $32.5M debt paid since Jan 2024.
- **Margins**: Gross margin 52% (up 250bps YoY), Financial Health 46% (up 150bps YoY), Patient Care 62% (up 400bps YoY).
- **Cost Efficiency**: $1M+ savings from resource management, India office, and encoder mix shift.

**【Q&A Highlights】**
- **Savings Pacing**: Client support modernization to yield low-single-digit million savings Q4+; mid-20s EBITDA margin target by 2026.
- **OB3 Impact**: Clients planning for Medicaid eligibility changes; potential 2025H2 headwinds, long-term opportunity for TruBridge.
- **Retention Trends**: Patient Care retention >95%; Financial Health CBO renewals improving sequentially, Encoder bookings up 13% QoQ.
- **Viewgol Integration**: Captive model benefits offset by implementation complexity; India office to accelerate offshore adoption in 2026.
- **Attrition Insights**: 70%+ attrition due to in-sourcing; relationship-driven recovery strategy with U.S.-based account teams.


TruBridge, Inc. (TBRG) Q2 2025 Earnings Call Transcript

- **Revenue Beat**: Q1 2025 revenue of $87 million (+3.7% YoY) exceeded expectations, driven by 5% growth in Financial Health core business.
- **Booking Strength**: $22 million Q1 bookings (ACV $17.3 million) included two strategic 100-400-bed hospital wins, up 50% sequentially in Financial Health.
- **Leverage Reduction**: Net debt/EBITDA improved to 2.4x vs. 4.4x a year ago, with $26 million debt repayment since Q1 2024.
- **Automation Savings**: Mid-single-digit million cost savings expected from offshore workforce transition and AI adoption in 2025.
- **Customer Resilience**: 98% Patient Care retention rate; hospitals prioritize revenue cycle management despite macro uncertainty.


**【CEO Summary Section】**
- **Revenue Growth**: Q1 2025 revenue of $87 million exceeded guidance, up 3.7% YoY (6.5% adjusted for divestitures). Financial Health revenue grew 5%, driven by core CBO business expansion.
- **Bookings Momentum**: Q1 bookings totaled $22 million (ACV $17.3 million), with 50% sequential growth in Financial Health and 60% in Patient Care. Notable wins included two 100-400-bed hospital deals via land-and-expand strategy.
- **Operational Initiatives**: 
  - Global workforce transition: 30% of CBO clients now offshore, targeting 60% by end-2025.
  - Automation investment: AI-driven RCM workflow automation to enhance efficiency.
  - Customer retention: 98% Patient Care retention rate, 9/11 renewals in Financial Health pipeline.
- **Policy Impact**: Hospitals cautious on capital allocation amid healthcare funding uncertainty, but core need for revenue cycle management remains strong.

**【CFO Financial Commentary】**
- **Profitability**: Adjusted EBITDA of $18.2 million (20.9% margin) up 860bps YoY, driven by revenue growth and $2 million timing benefits.
- **Cash Flow**: Operating cash flow improved $7.4 million YoY to $5.4 million; net leverage ratio reduced to 2.4x from 4.4x a year ago.
- **Guidance Update**: Full-year 2025 revenue $345-360 million, EBITDA $60-66 million (up from $59-66 million). Q2 revenue expected to decline due to $3 million conference costs and $1 million revenue timing shifts.
- **Cost Optimization**: $3 million debt repayment in Q1, total $26 million since Q1 2024. Offshore transition expected to deliver mid-single-digit million savings in 2025.

**【Q&A Highlights】**
- **Policy Risks**: Tariffs and healthcare funding uncertainty causing customer caution, but revenue cycle management remains critical. No direct tariff impact on TruBridge operations.
- **Automation Progress**: Early-stage AI adoption in RCM workflows, with focus on standardizing processes for scalability.
- **Retention Outlook**: 98% Patient Care retention rate stable; Financial Health renewals tracking to plan despite macro uncertainty.
- **SaaS Transition**: Patient Care bookings increasingly recurring (90%+ new deals), reducing one-time implementation revenue volatility.


TruBridge, Inc. (TBRG) Q1 2025 Earnings Call Transcript

- **2024 Strong Finish**: Q4 revenue $87.4M (+2% YoY), EBITDA $17.2M (+44% YoY). Full-year EBITDA $53M (+12% YoY), cash flow $32M vs. $1M in 2023.
- **Global Workforce Payoff**: 30% of CBO clients onshore, targeting 60% in 2025. Q4 gross margin 53% (vs. 44.7% in 2023), driven by $6M cost savings.
- **nTrust Growth Engine**: 24 deals in 2024 (vs. 18 in 2023). 75% of lost deals due to "no decision" vs. competition.
- **2025 Guidance**: 4% revenue growth, EBITDA $59-66M. 60 key CBO renewals over 24 months, 1/3 EHR customers to SaaS.
- **Risk Management**: 3x leverage ratio (down from 4x). 2025 free cash flow target 29% of EBITDA.
- **Key Metrics**: 53% gross margin, 19.7% EBITDA margin, $12.3M cash on hand.

**【CEO Summary Section】**
- **2024 Financial Highlights**: Q4 revenue of $87.4M (+2% YoY), adjusted EBITDA of $17.2M (+44% YoY). Full-year revenue $339M, adjusted EBITDA $53M (+12% YoY). Cash flow from operations improved to $32M vs. $1M in 2023.
- **Global Workforce Strategy**: 30% of CBO clients now supported by global teams, targeting 60% in 2025. Q4 gross margin expanded to 53% (vs. 44.7% in 2023), driven by cost savings and offshore transitions.
- **nTrust Growth**: nTrust deals grew from 14 in 2022 to 24 in 2024. 75% of deals lost due to "no decision" rather than competition, highlighting market opportunity.
- **2025 Priorities**: 4% revenue growth, EBITDA margin expansion, 60 key CBO renewals over 24 months, and SaaS conversion of 1/3 of EHR customers.

**【CFO Financial Commentary】**
- **Cash Flow & Debt**: Free cash flow $15.5M in 2024 (vs. -$22M in 2023). Net debt reduced to $159M with leverage ratio 3x (from 4x in 2023). Q4 cash flow from ops $10.3M (+$23M YoY).
- **Margins & Efficiency**: Q4 adjusted EBITDA margin 19.7% (vs. 14% in 2023Q4). Capitalized software as % of revenue dropped to 4.3% (from 6.8% in 2023). 2025 guidance: revenue $345-360M, EBITDA $59-66M.
- **One-Time Items**: Q4 included $2M of nonrecurring Patient Care revenue and $1M of onetime labor savings. Sequential margin expansion tempered by annual conference and merit increases.

**【Q&A Key Takeaways】**
- **Bookings Visibility**: 2024Q4 bookings $14M (vs. $21M in Q3). 60% of 2025 bookings expected in H2. 60 key CBO renewals over 24 months with >100% retention rate to date.
- **Sales Cycle & Pricing**: 40% of bookings open and close in same quarter. No decision rate remains high but 50%+ win rate when decision made. SaaS conversions not material to near-term growth but improve predictability.
- **Competitive Position**: 75% of lost deals due to "no decision" vs. competition. nTrust cross-sell success (24 deals in 2024) and Viewgol growth offset EHR declines.
- **2025 Outlook**: Financial Health (+7% YoY) to drive growth, Patient Care (+low single digits) from new products. 200+ basis points margin expansion through global workforce and cost control.

TruBridge, Inc. (TBRG) Q4 2024 Earnings Call Transcript

TruBridge, Inc. (TBRG) Q3 2024 Earnings Call Transcript

TruBridge, Inc. (TBRG) Q2 2024 Earnings Call Transcript

TruBridge, Inc. (TBRG) Q1 2024 Earnings Call Transcript

TruBridge (TBRG)-29 Feb 24-2023 Q4 Earnings call transcript

Computer Programs & Systems (CPSI)-8 Nov 23-2023 Q3 Earnings call transcript

- **Q2 Results**: Revenue $84.6M, EBITDA $11.2M (down 14% YoY) due to RCM underperformance and cost pressures.
- **Key Challenges**: SaaS contract shift, labor costs (+13% in RCM), and services-heavy RCM mix (60% of bookings vs. expected balance).
- **Cost Actions**: $3M annual savings from workforce reduction, 130 exits; 203 offshore employees (target 400 by year-end).
- **Guidance Update**: EBITDA revised to $52.5-54.5M (from $59-63M), revenue maintained at $340-350M.
- **Long-Term Outlook**: 20%+ EBITDA margin achievable via automation and globalization, but 2024 details pending.

**【CEO Summary Section】**
- Q2 revenue: $84.6 million, with RCM underperformance due to contract mix shift (SaaS vs. term licenses) and lower-than-expected volume.
- Adjusted EBITDA: $11.2 million (vs. $13.2 million YoY), driven by fixed cost absorption and labor pressures.
- Positive trends: EHR retention at high end of projections, two $1M+ RCM cross-sell contracts, and a $1.5M competitive EHR win post-quarter.
- Cost-saving measures: $3M annualized savings from voluntary retirement program, 130 employees exited.
- 2023 outlook: Revenue guidance maintained ($340-350M), EBITDA revised to $52.5-54.5M due to RCM services mix, cloud migration costs, and labor headwinds.

**【CFO Financial Commentary】**
- Net patient revenue: $3.2B (+9% YoY), RCM bookings $13.6M (62% of total), with 74% cross-sell to EHR customers.
- Gross margin: 47.8% (vs. 49.2% Q1), pressured by domestic labor costs (+13% in RCM).
- Operating expenses: 50.1% of revenue (vs. 43.6% YoY), driven by cloud migration, severance, and global workforce scaling.
- Q3 outlook: Flat revenue vs. Q2, EBITDA expected to improve sequentially.

**【Q&A Highlights】**
- **Pipeline Conversion**: Decision times doubled in 2023 vs. 2022, but 90%+ win rate on demos. Expect acceleration as labor shortages intensify.
- **Margin Pressures**: Services-heavy RCM mix (30% GM vs. 70% for tech) and domestic labor costs (+10% YoY). Global workforce (203 employees as of Q2, target 400 by year-end) expected to alleviate but not fully offset 2023 costs.
- **Future Growth**: Long-term path to 20%+ EBITDA margin via automation and offshore scale, but 2024 guidance pending.


Computer Programs & Systems (CPSI)-9 Aug 23-2023 Q2 Earnings call transcript

- **Revenue Growth**: Q1 revenue up 11% YoY to $86.2 million, with RCM at 56% of total. 
- **RCM Momentum**: Bookings +41% YoY, $2 million nTrust deal, and 700 EHR customers at client conference. 
- **Gross Margin Outlook**: 49% for 2023, targeting 50% in Q4 with offshore expansion. 
- **Pipeline Strength**: RCM pipeline doubled YoY, cross-sell占47% of bookings. 
- **EHR Stability**: 95% retention, 30% NPS improvement, supporting cross-sell strategy.

**【CEO Summary】**
- Q1 revenue of $86.2 million, up 11% YoY, driven by RCM growth (56% of total revenue). 
- RCM bookings surged 41% YoY, with 47% from cross-selling to existing EHR customers. 
- Signed a $2 million nTrust contract, bundling RCM and EHR services for four hospitals. 
- RCM pipeline doubled YoY, with 700 EHR customers attending the National Client Conference. 
- Offshore team expanded to 146 (target 400 by end-2023) to support RCM growth. 
- EHR retention at 95%, with NPS up 30% YoY, reflecting improved customer satisfaction. 

**【CFO Financial Commentary】**
- RCM revenue: $48.6 million (56% of total), EHR: $35.2 million. 
- Gross margin 49%, expected to stabilize at 49% for 2023, rising to 50% in Q4. 
- Offshore team growth to 400 by year-end to offset RCM margin pressures. 
- Full-year guidance: $340-350 million revenue, $59-63 million adjusted EBITDA. 
- OpEx up due to Azure migration, marketing, and client conference costs ($1.2 million). 

**【Q&A Highlights】**
- **Booking cadence**: RCM bookings convert to 1-year revenue vs. 5-year EHR, reducing lumpiness. 
- **Offshoring risks**: 18-month planning ensured service quality, with workflows tested before offshore transition. 
- **EHR retention**: 95% target met, with cross-sell pipeline supported by strong customer satisfaction. 
- **NPR growth**: Slower due to acquisition mix, but RCM services (e.g., Central Business Office) driving higher-margin revenue.

Computer Programs & Systems (CPSI)-9 May 23-2023 Q1 Earnings call transcript

- **Revenue Growth**: 18% YoY to $83 million, driven by TruBridge expansion and HRG acquisition.
- **Cross-Sell Momentum**: Cross-sell bookings up 30% sequentially, with pipelines tripling.
- **Leadership Shifts**: New COO and GMs to streamline operations and drive growth.
- **GRH Challenges**: $1-2M revenue delay due to customer-specific issues, not a market trend.
- **Financial Adjustments**: EBITDA margin revised to 17%-17.5% for FY22 due to GRH delays.

**【CEO Summary Section】**
- **Revenue and EBITDA Growth**: Total revenue of $83 million, up 18% YoY, with EBITDA of $13.3 million, a 9% YoY increase. TruBridge revenue grew 39% YoY, driven by HRG acquisition and organic expansion.
- **TruBridge Momentum**: Cross-sell bookings increased 30% sequentially, with a 3-year cross-sell opportunity of $300-$400 million. 3-month and 6-month weighted pipelines tripled to $17.3 million and $27 million, respectively.
- **Leadership Changes**: David Dye transitioned to COO, overseeing three business units led by new GMs: Patrick Murphy (TruBridge), Christina Hendricks (GRH), and David Harse (EHR). Dawn Severance became Chief Sales Officer.
- **Strategic Focus**: Shift to recurring revenue, automation, and offshoring. Investments in adjacencies like GRH and cloud migration. Disciplined capital allocation with $4 million in share buybacks.

**【CFO Financial Commentary】**
- **Revenue Breakdown**: TruBridge ($47.9M, +39% YoY), GRH ($1M), TruCode ($3.5M), HRG ($9.9M). System sales flat YoY, with recurring revenue up low single digits.
- **Gross Margin Challenges**: 45.9% gross margin (-440bps YoY) due to HRG's lower margins and GRH delays. Operating expenses improved to 39.9% of revenue (-400bps YoY).
- **Cash Flow**: Operating cash flow of $11.1 million, up 8.5x YoY. EBITDA margin guidance revised to 17%-17.5% for FY22 (from 18.25%-19.25%) due to GRH delays.
- **Share Buybacks**: $4 million repurchased in Q3, reflecting confidence in long-term strategy.

**【Q&A Key Highlights】**
- **Pricing Environment**: No significant price hikes from competitors; renewals include capped inflation adjustments (3%-5%).
- **GRH Delays**: Isolated customer issues (EHR integration, go-to-market timing) caused $1-2M revenue delay, not indicative of broader trends.
- **i2i Partnership**: Rev share agreement with i2i Population Health to enhance value-based care reporting. Expected 2023 contribution negligible, long-term potential significant.

Computer Programs & Systems (CPSI)-1 Nov 22-2022 Q3 Earnings call transcript

- **Revenue Growth**: 21% YoY recurring revenue growth (92% of total), with TruBridge bookings up 50% YoY and HRG/TruCode contributing $21M+ in Q2 revenue.
- **Strategic Investments**: $80M 2024 EBITDA target with focus on AI/automation, reduced service go-live lag, and U.S. digital front door expansion.
- **Financial Challenges**: Q2 EBITDA down 8% YoY due to $2.4M sales/marketing spend and $2M health claims spike, but CFO expects normalization.
- **M&A Momentum**: HRG outperformed with $10.8M Q2 revenue and $1.8M EBITDA, while TruCode added $3.3M revenue. Synergies exceed $3M annual run rate.
- **Risk Factors**: Elective service volume sensitivity in a recession, though TruBridge's recurring model provides stability.

**【CEO Summary Section】**
- **Revenue and Bookings Growth**: Q2 revenue and bookings exceeded expectations, driven by 21% year-over-year recurring revenue growth (92% of total revenue) and TruBridge's organic bookings up 50% YoY. HRG and TruCode contributed $14.6M and $6.7M in year-to-date revenue, respectively.
- **Strategic Focus**: Emphasized AI and automation investments to improve margins, with a goal to achieve $80M EBITDA by 2024. Cross-sell success into Evident EHR base reached $7.7M, and TruCode secured a $1.2M enterprise deal.
- **Operational Highlights**: Get Real Health's successful U.S. deployment with Steward Medical Group and reduced service go-live lag due to increased internal/offshore resources.

**【CFO Financial Commentary】**
- **Financial Performance**: GAAP net income of $5M, with adjusted EBITDA of $14.6M (down 8% YoY due to higher sales/marketing costs and health claims). Non-GAAP EPS was $0.35, below expectations.
- **Acquisition Impact**: HRG outperformed expectations, contributing $10.8M in Q2 revenue and $1.8M EBITDA, with $3M+ annual cost synergies identified. TruCode added $3.3M revenue and $1.6M EBITDA.
- **Margin Challenges**: Gross margin declined to 46% due to HRG's lower-margin services. Health claims costs surged $2M YoY, but CFO expects normalization in future quarters.
- **Capital Allocation**: $4.4M invested in capitalized software, $2.6M in share buybacks, and $50M revolver expansion for M&A flexibility.

**【Q&A Key Highlights】**
- **TruBridge Success Drivers**: HRG's sales talent and labor shortages in healthcare drove net new bookings up 4x YoY. Cross-sell into EHR base and enterprise wins (e.g., $1.2M TruCode deal) were key.
- **M&A Strategy**: Focus on consolidating similar services (e.g., HRG) and cross-sell opportunities (e.g., TruCode). Pipeline includes tuck-ins to enhance TruBridge offerings.
- **Margin Outlook**: Automation and offshoring will improve margins, but near-term investments in sales and AI will constrain EBITDA growth.
- **Recession Risks**: Potential decline in elective services could impact revenue, but TruBridge's recurring nature provides resilience. CFO expects health claims volatility to subside.

Computer Programs & Systems (CPSI)-2 Aug 22-2022 Q2 Earnings call transcript

Computer Programs & Systems (CPSI)-4 May 22-2022 Q1 Earnings call transcript

Computer Programs & Systems (CPSI)-16 Feb 22-2021 Q4 Earnings call transcript

Computer Programs & Systems (CPSI)-10 Nov 21-2021 Q3 Earnings call transcript

Computer Programs & Systems (CPSI)-7 Aug 21-2021 Q2 Earnings call transcript

- **Cost Savings Ambition**: $11M-$15M annualized savings by 2024, with $1M-$2M achieved in Q1 2021.
- **TruBridge Growth**: Revenue up 11% YoY to $31.6M, gross margin improving 280bps to 49%.
- **Bookings Recovery**: $10M Q1 shortfall, but pipeline at pre-pandemic levels with goal to recover by year-end.
- **SaaS Momentum**: Acute care SaaS revenue up 51% YoY, 5 new SaaS implementations planned for Q2.
- **Balance Sheet Strength**: $30M debt reduction, $55M trailing 12-month cash flow, $30M share buyback program active.

**【CEO Opening Remarks】**
- **Transformation Plan Progress**: Emphasized three pillars - core growth, margin optimization, and digital innovation. TruBridge revenue reached $31.6M, with 90% of total revenue recurring. 
- **Cost Savings Initiative**: Targeting $11M-$15M annualized savings by 2024 through automation, outsourcing, and lean methodologies. Q1 2021 saw $1M-$2M cost savings, with $7M-$9M expected by end-2022.
- **COVID Impact**: First-quarter bookings ($8.8M) missed expectations due to pandemic-related delays, but pipeline improved to pre-pandemic levels. Retention rate remained stable at 95%.

**【CFO Financial Commentary】**
- **Revenue Performance**: Total revenue of $129.4M (down 2.5% YoY) driven by 7% YoY growth in recurring revenue. TruBridge revenue up 11% YoY to $31.6M, with gross margin improving 280bps to 49%.
- **Profitability**: Adjusted EBITDA of $11.8M (flat YoY) with EBITDA margin expanding 40bps to 17.4%. Non-GAAP EPS of $0.64 beat expectations, supported by lower tax rate.
- **Cash Flow & Debt**: Operating cash flow of $13.7M (80% YoY increase) reduced debt by $30M, with $55M trailing 12-month cash flow. Share buybacks of $350K executed under $30M repurchase program.

**【Q&A Highlights】**
- **Bookings Outlook**: Q1 bookings lag by $10M, but pipeline improved to pre-pandemic levels. Expect to recover by year-end with 3-month pipeline at highest since Q4 2019.
- **Real Estate Strategy**: Minimal CapEx impact ($250K/year) from office renovations. Focus on remote/hybrid work model with reduced footprint.
- **SaaS Transition**: Acute care SaaS revenue up 51% YoY, post-acute recurring revenue up 2.6% QoQ. 5 new SaaS implementations planned for Q2.
- **M&A Strategy**: Prioritize TruBridge growth through disciplined acquisitions, with $80M EBITDA target achievable organically plus M&A upside.

Computer Programs & Systems (CPSI)-11 May 21-2021 Q1 Earnings call transcript

Computer Programs & Systems (CPSI)-10 Feb 21-2020 Q4 Earnings call transcript

Computer Programs & Systems (CPSI)-7 Nov 20-2020 Q3 Earnings call transcript

Computer Programs & Systems (CPSI)-9 Aug 20-2020 Q2 Earnings call transcript

Computer Programs & Systems (CPSI)-10 May 20-2020 Q1 Earnings call transcript

- **SaaS Growth Accelerating**: Q4 SaaS mix 54% (vs. 12% in 2018), driving 5-8% annual recurring revenue growth through 2023. 
- **Record Cash Flow**: $18 million Q4 operating cash flow, reducing leverage to 2x. 
- **TruBridge Expansion**: 2020 target to convert 16 EHR customers to nTrust, targeting $1 billion TAM. 
- **International Momentum**: Caribbean and Canadian deals expand EHR footprint outside US. 
- **Margin Outlook**: 2020 EBITDA margin 18-19%, improving as SaaS contracts mature. 
- **Capital Flexibility**: $75 million available for M&A or buybacks with 2x leverage.

**【CEO Summary Section】**
- **Revenue Growth and SaaS Transition**: Total bookings increased 20% year-over-year in the second half of 2019, with Q4 software system bookings reaching $51 million. SaaS mix rose to 54% in Q4 (vs. 12% in 2018), driving recurring revenue growth. 
- **International Expansion**: Secured $2.1 million acute EHR contract in the Caribbean and announced a Canadian partnership for a hospital information system. 
- **TruBridge Momentum**: 2019 bookings of $109 million (+9% YoY), with 10 EHR customers converted to nTrust packages. 2020 target: 16 conversions, targeting a $1 billion TAM. 
- **Cash Flow Strength**: Q4 operating cash flow hit $18 million (nearly double 2018), reducing leverage to 2x. 
- **Long-Term Targets**: 5-8% annual recurring revenue growth through 2022, with 80%+ SaaS mix by 2023.

**【CFO Financial Commentary】**
- **Q4 Financials**: 
  - Total revenue: $72.3 million (down 2% YoY due to SaaS transition)
  - Adjusted EBITDA: $13.6 million (up 4% YoY)
  - Non-GAAP EPS: $0.41 (vs. $0.38 YoY)
  - Operating cash flow: $18 million (record high)
- **Recurring Revenue**: 84% of 2019 revenue was recurring, up from 75% in 2018. SaaS mix for new EHR deals reached 50% in 2019 (vs. 12% in 2018). 
- **Margin Outlook**: 2020 adjusted EBITDA margin expected at 18-19% (vs. 20%+ pre-SaaS shift), improving over time. 
- **Capital Allocation**: $75 million available for M&A or buybacks, with leverage at 2x (target 2.5x). 
- **2020 Guidance**: Recurring revenue growth 5-8%, total revenue $280-290 million.

**【Q&A Highlights】**
- **SaaS Transition Impact**: 2020 EBITDA margin compression due to 50%+ SaaS mix, but 2023+ margins to improve as SaaS contracts mature. 
- **TruBridge Growth**: 2020 bookings target $110-120 million, with 25%+ growth from non-CPSI EHR clients. 
- **Get Real Health (GRH)**: Q4 GRH revenue $2.7 million (50% non-recurring), 2020 pipeline supports $5-10 million growth. 
- **Competitive Landscape**: Athena exit and Cerner reduced activity in small hospitals creating opportunities. 
- **Cash Flow Utilization**: Board evaluating buybacks, tuck-in M&A, or debt reduction. 
- **2021 Outlook**: Recurring revenue growth to accelerate post-2020 SaaS transition, with 2021 margin improvement.

Computer Programs & Systems (CPSI)-11 Feb 20-2019 Q4 Earnings call transcript

Computer Programs & Systems (CPSI)-10 Nov 19-2019 Q3 Earnings call transcript

Computer Programs & Systems (CPSI)-9 Aug 19-2019 Q2 Earnings call transcript

Computer Programs & Systems (CPSI)-5 May 19-2019 Q1 Earnings call transcript

- **Revenue Milestones**: TruBridge surpasses $100 million, nTrust secures $3 million in bookings, and 18 clients migrate to Thrive.
- **Financial Strength**: Q4 2018 non-GAAP EPS of $1.08, operating cash flow of $9.1 million, and 79% recurring revenue.
- **Growth Drivers**: 25% sequential bookings growth, 28-30 net new installations in 2019, and $10 million cost savings.
- **Strategic Initiatives**: Apple Health partnership, SaaS model expansion, and MU3 transition completion.
- **Margin Focus**: Targeting mid-teens TruBridge growth and 20% EBITDA margin through cost optimization.

**【CEO Summary Section】**
- CPSI ended 2018 with strong momentum, achieving $100 million in TruBridge revenue and $3 million in bookings for the nTrust SaaS offering.
- The company secured a significant contract with University of Louisville Physicians, expanding TruBridge's reach into larger healthcare organizations.
- Announced a partnership with Apple to integrate patient health records into the Apple Health app, enhancing patient engagement.
- Highlighted 18 Centriq/Classic-to-Thrive migrations and 29 net new acute EHR installations, reflecting client loyalty and market share growth.
- Emphasized 2019 goals of achieving $10 million in incremental cost savings and improving gross margins through subscription models.

**【CFO Financial Commentary】**
- Q4 2018 revenue: $72.3 million (4% sequential growth, 3% YoY growth).
- Non-GAAP EPS: $1.08 (matching Q3 record, +24% YoY).
- Adjusted EBITDA: $16.1 million for the year (28% sequential growth in Q4).
- Operating cash flow: $9.1 million (Q4) and $16.1 million (H2 2018), driven by recurring revenue (79% of Q4 revenue).
- Total bookings: $15.9 million (25% sequential growth), with TruBridge bookings up 6% sequentially and 41% YoY.
- MU3-related revenue decline ($12.3 million in Q4 2017 vs. $3.1 million in Q4 2018) offset by recurring revenue growth.
- 2019 outlook: 28-30 net new Thrive installations and $10 million in cost savings initiatives.

**【Q&A Highlights】**
- **Backlog Split**: $228 million recurring, $29 million non-recurring (Q4 2018).
- **2019 Installations**: 28-30 net new Thrive implementations (vs. 29 in 2018).
- **Cost Savings**: $10 million incremental savings expected in 2019, with Q4 2018 as a baseline run rate.
- **MU3 Impact**: $1.4 million of remaining MU3 bookings to be recognized in Q1 2019.
- **TruBridge Growth**: 85-90% of bookings from existing CPSI clients, targeting mid-teens annual growth.
- **nTrust Conversion**: Potential for 50%+ of clients to adopt SaaS model, adding $400,000+ annual revenue per client.
- **M&A Strategy**: Focus on tuck-in acquisitions to accelerate TruBridge growth, with balance sheet leverage at 2.5x (target 2.5x).


Actual											0.61	0.39	0.67	0.55	0.64	0.75	0.59	0.7	0.81	0.59	0.57	0.61	0.58	0.4	-0.24	-2.92	-0.17	-0.34	-0.66	0.05	0.36	0.54	0.88	0.79
Forecast											0.5677	0.3766	0.5178	0.7007	0.5547	0.5547	0.6352	0.5703	0.6603	0.6555	0.6572	0.585	0.6993	0.5844	0.4197	-0.0596	-0.2988	-0.2798	-0.0906	0.0412	0.2913	0.2974	0.5905	0.637
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+7.45%	+3.56%	+29.39%	-21.51%	+15.38%	+35.21%	-7.12%	+22.74%	+22.67%	-9.99%	-13.27%	+4.27%	-17.06%	-31.55%	-157.18%	-4799.33%	+43.11%	-21.52%	-628.48%	+21.36%	+23.58%	+81.57%	+49.03%	+24.02%

TBRG(Delisted)

TBRG(Delisted)

TruBridge (TBRG) Earnings

TBRG Q4 2025 Earnings

EPS

Revenue

Earnings Call

You can ask Aime